Early Drug Development Summit 2012
03 Dec 2012 - 04 Dec 2012 - Berlin, Germany
The Early Drug Development Summit is taking place on 3rd-4th December 2012 at the Hotel Palace Berlin, Germany.
This leading industry summit brings early drug developers together to discuss maximising drug investments, toxicology, safety and biomarkers.
How should companies address strategies and tools to fully optimise their drug development trajectory to bringing safe, effective and commercially viable drugs to market faster whilst achieving regulatory approval?
• Andreas Schneider, Vice President Life Science Alliances, Roche -
Maximising drug investments by effectively managing early drug development pipelines through the use of knowledge management.
• Dr Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer HealthCare
Obtaining grants for biomarkers – setting up open innovation in drug development between industry and academia
• Amer Alghbban, Director Global Quality Auditing, Merck Serono
Overcoming stringent regulatory barriers – accelerating drug approvals by meeting the requirements of ICH S4
Find out more at www.eddsummit.com
Save £300 on your registration when booking on www.eddsummit.com/offer
For further information or to book your place email Michaela Melcher, firstname.lastname@example.org or call +44(0)20 7202 7690